Opinion|Videos|September 16, 2024
The Link Between Obesity and CRM Conditions
Key Takeaways
- Obesity management is crucial in patient-centered care for cardiometabolic conditions, affecting disease progression and treatment outcomes.
- Challenges in managing CRM conditions in obese patients include medication dosing, comorbidities, and lifestyle modification adherence.
Experts in the field of cardiometabolic risk management analyze the link between obesity and cardiometabolic conditions, outlining challenges and proposing potential solutions.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How does the management of obesity factor into the patient centered care for patients with these CRM conditions?
- Are there any specific challenges in managing CRM conditions in patients with obesity? How can these challenges be addressed?
- What specific strategies have you implemented to both prevent and treat the complex disease of obesity?
- Can you share any success stories or case studies where weight management interventions have led to improvements in CRM conditions?
This activity is supported by Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Company who provided financial support for this program.
Advertisement
Related to this article
These phase 3 EXCALIBER-RRMM findings build on earlier MRD-negative complete response results supporting FDA approval of the iberdomide-based regimen.
At a roundtable in Cleveland, kidney experts said IgA nephropathy and FSGS often go unrecognized, calling for EHR flags and better referral channels.
AI quantitative CT (UCLA QILD, Brainomix e-Lung) predicts FVC decline and drug response in PPF, strengthening biomarkers beyond spirometry in INBUILD.
The conference session featured updates on several clinical trials, including the BRUNELLO trial, for treatment of diabetic macular edema (DME).
Panelists engaged in a debate regarding using complement inhibitors in geographic atrophy, gauging public sentiment with a deciding vote.
A session at AAO 2026 highlighted how big data and minimally invasive glaucoma surgery (MIGS) could be utilized to help patients receive peak care.
Medicaid expansion was associated with lower colorectal cancer mortality, with the largest reductions in Hispanic patients and stage IV disease.
Cepheid's Connie Savor, MD, MBA, explains where its 13-pathogen respiratory panel fits in diagnostic stewardship and antibiotic decisions.
Advertisement
Advertisement
Trending on AJMC
1
Oral JAK Inhibitors Boost Hair Regrowth Odds in Alopecia Areata
2
CMS Rule Ends Medicaid, CHIP Funding for Pediatric Gender Care
3
Panel Calls for Earlier Detection, Clearer Pathways in Rare Glomerular Disease
4
Medicare Drug Price Negotiations Yield Uneven Out-of-Pocket Savings
5